Kazia Therapeutics Limited
KZIA
$6.75
$0.172.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.41M | -3.50M | -5.92M | -5.90M | -2.88M |
| Total Depreciation and Amortization | 304.50K | 313.10K | 307.80K | 307.20K | 304.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 708.90K | 728.90K | 1.52M | 1.51M | 236.60K |
| Change in Net Operating Assets | -350.90K | -360.80K | 3.02M | 3.02M | 269.80K |
| Cash from Operations | -2.74M | -2.82M | -1.07M | -1.07M | -2.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -300.00 | -300.00 | 388.30K |
| Total Debt Repaid | -- | -- | 400.00 | 400.00 | -185.90K |
| Issuance of Common Stock | 4.87M | 4.87M | 644.00K | 644.00K | 2.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -27.90K | -27.90K | -160.40K |
| Cash from Financing | 3.17M | 3.26M | 406.00K | 405.20K | 1.55M |
| Foreign Exchange rate Adjustments | 28.50K | 29.30K | 35.70K | 35.60K | -31.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 458.40K | 471.30K | -627.80K | -626.50K | -547.00K |